TG Group anti-cancer research featured in Irish Times Magazine

Trojan horse is activated by beam of light

As part of the inaugural TBSI-Weizmann joint meeting, July 27-29 2014, attended by 600 delegates including a number of Nobel laureates, a special supplement to the Irish Times was produced, showcasing some of the cutting-edge research underway in both institutions.

An article on ruthenium-based anti-cancer research in the group featured in this special supplement describing the ‘Trojan horse’ strategy for these light-activated agents.